Saunders, Nell https://orcid.org/0000-0002-0872-1529
Fernandez, Ignacio
Planchais, Cyril https://orcid.org/0000-0002-5142-7253
Michel, Vincent https://orcid.org/0000-0002-7025-4343
Rajah, Maaran Michael
Baquero Salazar, Eduard
Postal, Jeanne
Porrot, Francoise https://orcid.org/0000-0001-8995-3614
Guivel-Benhassine, Florence
Blanc, Catherine https://orcid.org/0000-0003-4214-1381
Chauveau-Le Friec, Gaëlle
Martin, Augustin
Grzelak, Ludivine
Oktavia, Rischa Maya
Meola, Annalisa
Ahouzi, Olivia
Hoover-Watson, Hunter
Prot, Matthieu
Delaune, Deborah https://orcid.org/0000-0003-4970-9566
Cornelissen, Marion
Deijs, Martin
Meriaux, Véronique
Mouquet, Hugo
Simon-Lorière, Etienne https://orcid.org/0000-0001-8420-7743
van der Hoek, Lia https://orcid.org/0000-0003-2803-642X
Lafaye, Pierre https://orcid.org/0000-0002-5761-1342
Rey, Felix https://orcid.org/0000-0002-9953-7988
Buchrieser, Julian https://orcid.org/0000-0003-4790-7577
Schwartz, Olivier https://orcid.org/0000-0002-0729-1475
Article History
Received: 7 April 2023
Accepted: 18 October 2023
First Online: 25 October 2023
Competing interests
: N.S., J.B., O.S., I.F., E.B.S., F.R. and P.L. have a provisional patent on anti-TMPRSS2 nanobodies. The other authors declare no competing interests.